Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Falini

Showing results (211-220 of 228) with videos related to

Pageof 23
Sort By:
Leukemia|August 5, 2005
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosminH Quentmeier, M P Martelli, W G Dirks, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. ClassificationS Ascani, P L Zinzani, F Gherlinzoni, et al.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
Leukemia|June 20, 2008
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemiaM P Martelli, N Manes, A Liso, et al.
Ejhaem|November 29, 2023
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemiaD Sorcini, A Stella, A Scialdone, et al.
The Histochemical Journal|November 25, 2003
Tyrosine phosphorylation in human lymphomasE Haralambieva, M Jones, G M Roncador, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Pageof 23

Showing results (211-220 of 228) with videos related to

Sort By:
Pageof 23
Leukemia|August 5, 2005
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosminH Quentmeier, M P Martelli, W G Dirks, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. ClassificationS Ascani, P L Zinzani, F Gherlinzoni, et al.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
Leukemia|June 20, 2008
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemiaM P Martelli, N Manes, A Liso, et al.
Ejhaem|November 29, 2023
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemiaD Sorcini, A Stella, A Scialdone, et al.
The Histochemical Journal|November 25, 2003
Tyrosine phosphorylation in human lymphomasE Haralambieva, M Jones, G M Roncador, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Pageof 23